FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says

 
• By Cathy Kelly
  
PBMs And Patents Are Two Important Drug Pricing Issues For Linda Khan and the FTC.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet